Business
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the definition of a digital therapeutic, companies in the DTx space, why the organization held its recent summit in D.C. and the status of the Prescription Digital Therapeutics Act.
HIMSS24
Dave Bailey, VP, Consulting Services at Clearwater Security, recommends developing cybersecurity strategy around a framework like NIST 2.0 and working with leadership to get the necessary resources to address vulnerabilities.
The company will use the funds to expand its team.
Dr. Dennis Truong, regional telemedicine/mobility director at Kaiser Permanente, highlights the challenges of implementing digital therapeutics in the care system and its ultimate value in improving patients' and providers’ care journeys.
Naama Stauber Breckler, CEO and cofounder of Better Health, discusses the company's latest strategic funding round and how it plans to use the investment.
HIMSS24
McGill University Health Centre's Dr. Alan Forster discusses the Quadruple Aim and using data to understand opportunities for development and improvement.
Andy Molnar, CEO of the Digital Therapeutics Alliance, and Scott Stuewe, president and CEO of DirectTrust, discuss their partnership to show digital therapeutics' value and accreditation in healthcare for payors considering DTx coverage.
HIMSS24
Dr. Calum Yacoubian, director of NLP healthcare strategy at IQVIA, says AI can support, not replace, clinicians in improving care delivery, and discusses some best practices for its safe and ethical use.
The HIMSS AI in Healthcare Forum is scheduled to take place September 5-6 in Boston. Learn more and register.
The acquisition expands NeuroFlow's capabilities for behavioral health-focused measurement and engagement.
HIMSS24
Kyruus Health president Paul Merrild discusses how the company aims to improve care access via its partnerships with health systems and payers and by pairing patients and providers using personalized information and provider availability.